China Biologic Schedules Conference Call to Discuss Third Quarter 2009 Financial Results
November 13 2009 - 9:00AM
PR Newswire (US)
TAI'AN CITY, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (OTC:CBPO) (BULLETIN BOARD: CBPO) ("China
Biologic," or the "Company"), one of the leading plasma-based
pharmaceutical companies in China, today announced that the Company
will host a conference call at 8:00 a.m. ET on Monday, November 16,
2009, to discuss the 2009 third quarter financial results ended on
September 30, 2009. Hosting the call will be Mr. Colin Zhao, Chief
Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. To
participate in the live conference call, please dial the following
number five to ten minutes prior to the scheduled conference call
time: 866-356-3093. International callers should dial
+1-617-597-5381. The pass code for the call is 91606809. If you are
unable to participate in the call at this time, a replay will be
available for 14 days starting on Monday, November 16, 2009 at
10:00 a.m. ET. To access the replay, dial 888-286-8010,
international callers should dial +1-617-801-6888. The conference
pass code is 78299906. About China Biologic Products, Inc. China
Biologic Products, Inc., through its indirect majority-owned
subsidiaries, Shandong Taibang Biological Products Co. Ltd. and
Chongqing Dalin Biologic Technologies Co., Ltd, and its equity
investment in Xi'an Huitian Blood Products Co., Ltd., is currently
the largest non-state-owned plasma-based biopharmaceutical company
in China. The Company is a fully integrated biologic products
company with plasma collection, production and manufacturing,
research and development, and commercial operations. The Company's
plasma-based biopharmaceutical products are irreplaceable during
medical emergencies, and are used for the prevention and treatment
of various diseases. The Company sells its products to hospitals
and other healthcare facilities in China. For more information
please visit the Company's website http://www.chinabiologic.com/
For more information, please contact: Company Contact: Mr. Y.
Tristan Kuo Chief Financial Officer China Biologic Products, Inc.
Tel: +86-538-6202206 Email: Web: http://www.chinabiologic.com/
Investor Relations Contact: CCG Investor Relations Mr. Athan
Dounis, Account Manager Tel: +1-646-213-1916 Email: Mr. Crocker
Coulson, President Tel: +1-646-213-1915 Email: Web:
http://www.ccgasiair.com/ DATASOURCE: China Biologic Products, Inc.
CONTACT: Company Contact: Mr. Y. Tristan Kuo, Chief Financial
Officer of China Biologic Products, Inc., +86-538-6202206, or ;
Investor Relations Contact: CCG Investor Relations - Mr. Athan
Dounis, Account Manager, +1-646-213-1916, or ; Mr. Crocker Coulson,
President, +1-646-213-1915, or Web Site:
http://www.chinabiologic.com/ http://www.ccgasiair.com/
Copyright